Search - tctmd.com

Displaying 321 - 340 of 378

Sort: Relevancy | Date

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

News Conference News ACC 2024

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

March 27, 2024

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

News Daily News

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

March 25, 2024

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

News Daily News

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

March 21, 2024

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

News Daily News

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

Michael O'Riordan

March 20, 2024

Internists in HF: A Solution to a Lack of Care?

News Daily News

Internists in HF: A Solution to a Lack of Care?

Yael L. Maxwell

March 19, 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

March 14, 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

News Daily News

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

March 11, 2024

FDA Grants MACE Reduction Indication for Semaglutide

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

March 08, 2024

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

March 07, 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Presentation THT 2024

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Presenter: Thomas Hanff

March 06, 2024

Semaglutide Winning Streak Continues in CKD With FLOW

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

March 06, 2024

A Novel Cardiac Scale and Algorithm for Detecting Worsening Congestion Preceding Heart Failure Events (HFEs): A Preliminary Analysis of the SCALE-HF 1 Study

Presentation THT 2024

A Novel Cardiac Scale and Algorithm for Detecting Worsening Congestion Preceding Heart Failure Events (HFEs): A Preliminary Analysis of the SCALE-HF 1 Study

Presenter: Marat Fudim

March 06, 2024

Novel Strategies in mRNA Therapeutics for Heart Failure

Presentation THT 2024

Novel Strategies in mRNA Therapeutics for Heart Failure

Presenter: John Cooke

March 05, 2024

Use of a Novel Intra-Aortic Entrainment Pump for a Patient With Restrictive Cardiomyopathy and Recurrent Cardiorenal Syndrome

Presentation THT 2024

Use of a Novel Intra-Aortic Entrainment Pump for a Patient With Restrictive Cardiomyopathy and Recurrent Cardiorenal Syndrome

Presenter: Davis Kimaiyo

March 05, 2024

A Case of Severe De Novo HF on Support for 14 days Without Evidence of Recovery

Presentation THT 2024

A Case of Severe De Novo HF on Support for 14 days Without Evidence of Recovery

Presenter: Elena M. Donald

March 04, 2024

Cardiac Myosin Inhibitors as a Novel Treatment Option for Nonobstructive Hypertrophic Cardiomyopathy

Presentation THT 2024

Cardiac Myosin Inhibitors as a Novel Treatment Option for Nonobstructive Hypertrophic Cardiomyopathy

Presenter: Ahmad Masri

March 04, 2024

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Presentation THT Abstracts 2024

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Presenter: Nadira Hamid

March 04, 2024

BiVacor: A Novel, Magnetically Levitated Rotary Pump-Based TAH

Presentation THT 2024

BiVacor: A Novel, Magnetically Levitated Rotary Pump-Based TAH

Presenter: Daniel Timms

March 04, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.